Home > Compound List > Product Information
Temsirolimus_Molecular_structure_CAS_162635-04-3)
Click picture or here to close

Temsirolimus

Catalog No. PZ0020 Name Sigma Aldrich
CAS Number 162635-04-3 Website http://www.sigmaaldrich.com
M. F. C56H87NO16 Telephone 1-800-521-8956
M. W. 1030.28708 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154888

SYNONYMS

IUPAC name
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
IUPAC Traditional name
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
Synonyms
CCI-779
42-[3-Hydroxy-2-methylpropanoate
Rapamycin

DATABASE IDS

MDL Number MFCD00934421
CAS Number 162635-04-3

PROPERTIES

Empirical Formula (Hill Notation) C56H87NO16
Purity ≥98% (HPLC)
Apperance white to off-white powder
Solubility DMSO: ≥20 mg/mL
MSDS Link Download
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Temsirolimus is a specific inhibitor of mammalian target of rapamycin (mTOR) mTOR Complex 1 (mTORC1). Temsirolimus is an antiproliferative and antiangiogenic, the first-in-class mTOR inhibitor approved for the treatment of patients with advanced poor prognosis renal cell carcinoma.
Description (简体中文)
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Temsirolimus is a specific inhibitor of mammalian target of rapamycin (mTOR) mTOR Complex 1 (mTORC1). Temsirolimus is an antiproliferative and antiangiogenic, the first-in-class mTOR inhibitor approved for the treatment of patients with advanced poor prognosis renal cell carcinoma.

REFERENCES